Avalo Therapeutics, Inc. (AVTX)
19.26
-0.57
(-2.87%)
USD |
NASDAQ |
Aug 24, 16:00
19.26
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics 1 Year Total Returns (Daily) : 111.6% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 111.6% |
| August 20, 2026 | 115.0% |
| August 19, 2026 | 133.3% |
| August 18, 2026 | 117.5% |
| August 17, 2026 | 121.2% |
| August 14, 2026 | 118.9% |
| August 13, 2026 | 114.3% |
| August 12, 2026 | 108.9% |
| August 11, 2026 | 116.2% |
| August 10, 2026 | 121.4% |
| August 07, 2026 | 119.4% |
| August 06, 2026 | 125.0% |
| August 05, 2026 | 129.8% |
| August 04, 2026 | 106.6% |
| August 03, 2026 | 128.8% |
| July 31, 2026 | 131.3% |
| July 30, 2026 | 191.1% |
| July 29, 2026 | 190.7% |
| July 28, 2026 | 196.7% |
| July 27, 2026 | 191.5% |
| July 24, 2026 | 178.1% |
| July 23, 2026 | 166.3% |
| July 22, 2026 | 182.7% |
| July 21, 2026 | 179.6% |
| July 20, 2026 | 191.4% |
| Date | Value |
|---|---|
| July 17, 2026 | 242.2% |
| July 16, 2026 | 268.7% |
| July 15, 2026 | 286.5% |
| July 14, 2026 | 275.9% |
| July 13, 2026 | 295.6% |
| July 10, 2026 | 292.0% |
| July 09, 2026 | 303.0% |
| July 08, 2026 | 296.1% |
| July 07, 2026 | 305.3% |
| July 06, 2026 | 302.4% |
| July 02, 2026 | 281.4% |
| July 01, 2026 | 257.2% |
| June 30, 2026 | 270.3% |
| June 29, 2026 | 303.6% |
| June 26, 2026 | 282.4% |
| June 25, 2026 | 275.8% |
| June 24, 2026 | 266.9% |
| June 23, 2026 | 272.2% |
| June 22, 2026 | 268.1% |
| June 18, 2026 | 208.8% |
| June 17, 2026 | 244.5% |
| June 16, 2026 | 210.8% |
| June 15, 2026 | 201.7% |
| June 12, 2026 | 202.5% |
| June 11, 2026 | 190.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.02% |
| Incyte Corp. | 47.71% |
| AbbVie, Inc. | 30.40% |
| Rezolute, Inc. | -26.87% |
| Alnylam Pharmaceuticals, Inc. | -49.48% |